These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25864659)

  • 1. Safety and regulatory issues regarding stem cell therapies: one clinic's perspective.
    Centeno CJ; Bashir J
    PM R; 2015 Apr; 7(4 Suppl):S4-S7. PubMed ID: 25864659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bench-to-bedside translation of stem cell therapies: where are we now and where are we going?
    Martino G
    Regen Med; 2016 Jun; 11(4):347-9. PubMed ID: 27188381
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulatory loophole enables unproven autologous cell therapies to thrive in Australia.
    Munsie M; Pera M
    Stem Cells Dev; 2014 Dec; 23 Suppl 1():34-8. PubMed ID: 25457959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administrative and research policies required to bring cellular therapies from the research laboratory to the patient's bedside.
    Yim R
    Transfusion; 2005 Oct; 45(4 Suppl):144S-58S. PubMed ID: 16181400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cell clinics online: the direct-to-consumer portrayal of stem cell medicine.
    Lau D; Ogbogu U; Taylor B; Stafinski T; Menon D; Caulfield T
    Cell Stem Cell; 2008 Dec; 3(6):591-4. PubMed ID: 19041775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concise review: mind the gap: challenges in characterizing and quantifying cell- and tissue-based therapies for clinical translation.
    Rayment EA; Williams DJ
    Stem Cells; 2010 May; 28(5):996-1004. PubMed ID: 20333747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell pharmacogenomics.
    Bapat SA; Mishra GC
    Curr Top Med Chem; 2004; 4(13):1371-83. PubMed ID: 15379651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteogenic stem-cell characterization and development: potentials for cytotherapy.
    Triffitt JT; Oreffo RO; Virdi AS; Xia Z
    Cytotherapy; 2001; 3(5):413-6. PubMed ID: 11953025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping and driving the stem cell ecosystem.
    Knoepfler PS
    Regen Med; 2018 Oct; 13(7):845-858. PubMed ID: 30289055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future challenges for hematopoietic stem cell research.
    Spangrude GJ
    Biotechniques; 2003 Dec; 35(6):1273-9. PubMed ID: 14682063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From bench to bedside: review of gene and cell-based therapies and the slow advancement into phase 3 clinical trials, with a focus on Aastrom's Ixmyelocel-T.
    Bartel RL; Booth E; Cramer C; Ledford K; Watling S; Zeigler F
    Stem Cell Rev Rep; 2013 Jun; 9(3):373-83. PubMed ID: 23456574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What's new in cell therapies in ARDS?
    Horie S; Curley GF; Laffey JG
    Intensive Care Med; 2016 May; 42(5):779-782. PubMed ID: 26626060
    [No Abstract]   [Full Text] [Related]  

  • 13. Phacilitate Cell and Gene Therapy Forum 2005: Driving gene therapies through preclinical and clinical development. 24-26 January 2005, Washington, DC, USA.
    Salmons B
    IDrugs; 2005 Mar; 8(3):200-2. PubMed ID: 15772887
    [No Abstract]   [Full Text] [Related]  

  • 14. Stem-Cell Therapy Advances in China.
    Hu L; Zhao B; Wang S
    Hum Gene Ther; 2018 Feb; 29(2):188-196. PubMed ID: 29284300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current approaches for the treatment of male infertility with stem cell therapy.
    Pourmoghadam Z; Aghebati-Maleki L; Motalebnezhad M; Yousefi B; Yousefi M
    J Cell Physiol; 2018 Oct; 233(10):6455-6469. PubMed ID: 29667717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Safety cell therapeutics/cell based medicinal products (CBMP)].
    Scherer J; Seitz R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Nov; 58(11-12):1199-200. PubMed ID: 26391096
    [No Abstract]   [Full Text] [Related]  

  • 17. Gene and Cell Therapies: Inserm at the Heart of Biomedical Revolutions.
    Lévy Y
    Hum Gene Ther; 2016 Feb; 27(2):98-9. PubMed ID: 26886831
    [No Abstract]   [Full Text] [Related]  

  • 18. Stem cell therapy for the treatment of Peyronie's disease.
    Dellis A; Papatsoris A
    Expert Opin Biol Ther; 2017 Apr; 17(4):407-413. PubMed ID: 28274142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Regenerative therapy for post-stroke patients].
    Yamashita T; Abe K
    Nihon Rinsho; 2016 Apr; 74(4):661-5. PubMed ID: 27333756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel therapies for the treatment of cystic fibrosis: new developments in gene and stem cell therapy.
    Sueblinvong V; Suratt BT; Weiss DJ
    Clin Chest Med; 2007 Jun; 28(2):361-79. PubMed ID: 17467554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.